187 related articles for article (PubMed ID: 29309830)
1. The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes.
Gabriele M; Lopez Tobon A; D'Agostino G; Testa G
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):306-327. PubMed ID: 29309830
[TBL] [Abstract][Full Text] [Related]
2. Annual research review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter.
Kiser DP; Rivero O; Lesch KP
J Child Psychol Psychiatry; 2015 Mar; 56(3):278-95. PubMed ID: 25677560
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of the epigenome in neurodevelopmental disorders.
Wilson KD; Porter EG; Garcia BA
Crit Rev Biochem Mol Biol; 2022 Feb; 57(1):73-112. PubMed ID: 34601997
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the genetic basis of comorbid epilepsy phenotypes in neurodevelopmental disorders.
Chow J; Jensen M; Amini H; Hormozdiari F; Penn O; Shifman S; Girirajan S; Hormozdiari F
Genome Med; 2019 Oct; 11(1):65. PubMed ID: 31653223
[TBL] [Abstract][Full Text] [Related]
6. Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders.
Bonini SA; Mastinu A; Ferrari-Toninelli G; Memo M
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933765
[TBL] [Abstract][Full Text] [Related]
7. Epigenomic Convergence of Neural-Immune Risk Factors in Neurodevelopmental Disorder Cortex.
Vogel Ciernia A; Laufer BI; Hwang H; Dunaway KW; Mordaunt CE; Coulson RL; Yasui DH; LaSalle JM
Cereb Cortex; 2020 Mar; 30(2):640-655. PubMed ID: 31240313
[TBL] [Abstract][Full Text] [Related]
8. The phenomenal epigenome in neurodevelopmental disorders.
Ciptasari U; van Bokhoven H
Hum Mol Genet; 2020 Sep; 29(R1):R42-R50. PubMed ID: 32766754
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective.
Mossink B; Negwer M; Schubert D; Nadif Kasri N
Cell Mol Life Sci; 2021 Mar; 78(6):2517-2563. PubMed ID: 33263776
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic priming in neurodevelopmental disorders.
Ernst C; Jefri M
Trends Mol Med; 2021 Dec; 27(12):1106-1114. PubMed ID: 34690045
[TBL] [Abstract][Full Text] [Related]
11. Soma-to-germline transformation in chromatin-linked neurodevelopmental disorders?
Bonefas KM; Iwase S
FEBS J; 2022 Apr; 289(8):2301-2317. PubMed ID: 34514717
[TBL] [Abstract][Full Text] [Related]
12. Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies.
Homberg JR; Kyzar EJ; Stewart AM; Nguyen M; Poudel MK; Echevarria DJ; Collier AD; Gaikwad S; Klimenko VM; Norton W; Pittman J; Nakamura S; Koshiba M; Yamanouchi H; Apryatin SA; Scattoni ML; Diamond DM; Ullmann JF; Parker MO; Brown RE; Song C; Kalueff AV
Expert Opin Drug Discov; 2016; 11(1):11-25. PubMed ID: 26558752
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of sleep and circadian ontogeny through the lens of neurodevelopmental disorders.
Barone I; Hawks-Mayer H; Lipton JO
Neurobiol Learn Mem; 2019 Apr; 160():160-172. PubMed ID: 30668981
[TBL] [Abstract][Full Text] [Related]
14. Investigation of genes important in neurodevelopment disorders in adult human brain.
Maussion G; Diallo AB; Gigek CO; Chen ES; Crapper L; Théroux JF; Chen GG; Vasuta C; Ernst C
Hum Genet; 2015 Oct; 134(10):1037-53. PubMed ID: 26194112
[TBL] [Abstract][Full Text] [Related]
15. Glutamatergic synapses in neurodevelopmental disorders.
Moretto E; Murru L; Martano G; Sassone J; Passafaro M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):328-342. PubMed ID: 28935587
[TBL] [Abstract][Full Text] [Related]
16. A molecular model for neurodevelopmental disorders.
Gigek CO; Chen ES; Ota VK; Maussion G; Peng H; Vaillancourt K; Diallo AB; Lopez JP; Crapper L; Vasuta C; Chen GG; Ernst C
Transl Psychiatry; 2015 May; 5(5):e565. PubMed ID: 25966365
[TBL] [Abstract][Full Text] [Related]
17. Nanoscale synapse organization and dysfunction in neurodevelopmental disorders.
Zieger HL; Choquet D
Neurobiol Dis; 2021 Oct; 158():105453. PubMed ID: 34314857
[TBL] [Abstract][Full Text] [Related]
18. Rare copy number variations affecting the synaptic gene DMXL2 in neurodevelopmental disorders.
Costain G; Walker S; Argiropoulos B; Baribeau DA; Bassett AS; Boot E; Devriendt K; Kellam B; Marshall CR; Prasad A; Serrano MA; Stavropoulos DJ; Twede H; Vermeesch JR; Vorstman JAS; Scherer SW
J Neurodev Disord; 2019 Feb; 11(1):3. PubMed ID: 30732576
[TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental synaptopathies: Insights from behaviour in rodent models of synapse gene mutations.
Luo J; Norris RH; Gordon SL; Nithianantharajah J
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):424-439. PubMed ID: 29217145
[TBL] [Abstract][Full Text] [Related]
20. Neurodevelopmental Disorders: From Genetics to Functional Pathways.
Parenti I; Rabaneda LG; Schoen H; Novarino G
Trends Neurosci; 2020 Aug; 43(8):608-621. PubMed ID: 32507511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
